
Researchers from the University of Missouri have found that a compound developed by Roche Pharmaceuticals for the treatment of high …

Merck has announced the appointment of Maya Martinez-Davis as the new global head of oncology at the German-based company. In …

EUSA Pharma has announced the acquisition of global rights to oncology support care product, Arcoral Tab, from Arcoral Pharma.

Midatech Pharma (NASDAQ: MTP) has the full commercial launch of Zuplenz (ondansetron) in the US. The drug is an oral …

Global gene sequencing company Illumina has won over $100 million in investment from high-profile investors, to create a company “to …

US pharma company MSD is to buy Edinburgh based IOMet Pharma to expand its existing R&D programme, exploring the development …

Immuno-oncology company PsiOxus Therapeutics has appointed Kesios Therapeutics chief executive, and former president of GSK Oncology, Dr Paolo Paoletti, as chairman …

Peter Culpepper, chief operating officer at Provectus Biopharmaceuticals, explains the secrets of Rose Bengal, which has impressed in clinical trials …

The molecular revolution over the last decade has done much to help turn cancer into an illness that can be …

Merck and Pfizer are partnering to run two Phase III trials of avelumab, an immuno-oncology treatment the companies hope to …

Amgen Amgen presented data from three Phase II trials evaluating Blincyto (blinatumomab) in acute lymphoblastic leukemia (ALL)- a rare and …

Janssen presented new cancer trial data at the 57th Annual American Society of Haematology (ASH) meeting Orlando, Florida – with …
Takeda UK has announced post-treatment follow up data from the pivotal Phase II study of Adcetris revealing a five-year survival …

The price of new cancer drugs varies widely between high-income countries in Europe, Australia, and New Zealand, new research published …

Clinigen and Takeda have struck a deal to allow patients in the UK to access the multiple myeloma drug ixazomib …